Vir Biotechnology Inc

NASDAQ:VIR   3:59:51 PM EDT
28.37
-0.04 (-0.14%)
Earnings Announcements

Vir Biotechnology Reports Third Quarter 2020 Financial Results

Published: 11/10/2020 21:12 GMT
Vir Biotechnology Inc (VIR) - Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.67.
Q3 Revenue $1.9 Million Versus $1.4 Million.
Q3 Revenue Estimate $19 Million -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share Estimate $-0.60 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.81 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $13.63 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.